The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...
A 20-year-old woman experienced on-and-off stomach pain, then sudden nausea and chills. She was diagnosed with stage 2 colon ...
MedPage Today on MSN
Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says
OS of 8.9 months versus 5.8 months with trifluridine/tipiracil alone, supporting phase III ...
Pfizer Inc. PFE shares are trending on Wednesday following the U.S. Food and Drug Administration’s (FDA) full approval of the BRAFTOVI combination regimen for treating metastatic colorectal cancer.
Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have ...
We are continuing our conversation about Colon Cancer, testing, and advancements in medical technology with Dr. Ryan ...
A 35-year-old dad and active snowboarder thought his stomach pain was from something he ate. It was colon cancer.
Colorectal cancer is highly treatable when caught early—and FIT tests make screening easier than ever with a simple at‑home ...
After learning about the genetic risks, Vorbe's mom received an early uterine cancer diagnosis. For years, Naiké Vorbe tried to ease her abdominal pain. A dietitian advised her to cut gluten and ...
Any blood in the stool—whether bright red, maroon, or black and tarry—should prompt immediate medical attention. For cases of left-sided colon cancer, blood in the stool is often one of the first ...
Developing assertiveness is portrayed as a protective shift from people-pleasing and emotional suppression toward clearer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results